170 related articles for article (PubMed ID: 3435078)
21. Pharmacological and biochemical assessment of SM-10888, a novel cholinesterase inhibitor.
Natori K; Okazaki Y; Irie T; Katsube J
Jpn J Pharmacol; 1990 Jun; 53(2):145-55. PubMed ID: 2385001
[TBL] [Abstract][Full Text] [Related]
22. Effects of tacrine, aminopyridines, and physostigmine on acetylcholinesterase, acetylcholine release, and potassium currents.
Harvey AL; Rowan EG
Adv Neurol; 1990; 51():227-33. PubMed ID: 2294657
[No Abstract] [Full Text] [Related]
23. [Tetrahydroaminoacridine: a promising 'therapy' for Alzheimer's disease?].
Drukarch B; Stoof JC
Ned Tijdschr Geneeskd; 1988 Oct; 132(40):1833-5. PubMed ID: 3185771
[No Abstract] [Full Text] [Related]
24. Direct comparison of cognitive facilitation by physostigmine and tetrahydroaminoacridine in two primate models.
Rupniak NM; Field MJ; Samson NA; Steventon MJ; Iversen SD
Neurobiol Aging; 1990; 11(6):609-13. PubMed ID: 2280804
[TBL] [Abstract][Full Text] [Related]
25. Cortisol responses to cholinergic drugs in Alzheimer's disease.
Kumar V; Smith RC; Sherman KA; Ashford W; Murphy J; Giacobini E; Colliver J
Int J Clin Pharmacol Ther Toxicol; 1988 Oct; 26(10):471-6. PubMed ID: 3069749
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of acetylcholinesterase activity in human brain tissue and erythrocytes by galanthamine, physostigmine and tacrine.
Thomsen T; Kaden B; Fischer JP; Bickel U; Barz H; Gusztony G; Cervos-Navarro J; Kewitz H
Eur J Clin Chem Clin Biochem; 1991 Aug; 29(8):487-92. PubMed ID: 1954303
[TBL] [Abstract][Full Text] [Related]
27. In vivo kinetics of blood cholinesterase inhibition by 9-amino-1, 2, 3, 4-tetrahydroacridine, its 7-methoxy derivative and physostigmine in rats.
Bajgar J; Fusek J; Patocka J; Hrdina V
Physiol Bohemoslov; 1979; 28(1):31-4. PubMed ID: 155828
[TBL] [Abstract][Full Text] [Related]
28. Acetylcholinesterase and its association with heparan sulphate proteoglycans in cortical amyloid deposits of Alzheimer's disease.
Kalaria RN; Kroon SN; Grahovac I; Perry G
Neuroscience; 1992 Nov; 51(1):177-84. PubMed ID: 1465181
[TBL] [Abstract][Full Text] [Related]
29. In vitro protection of acetylcholinesterase and butyrylcholinesterase by tetrahydroaminoacridine. Comparison with physostigmine.
Galli A; Mori F; Gori I; Lucherini M
Biochem Pharmacol; 1992 Jun; 43(11):2427-33. PubMed ID: 1610407
[TBL] [Abstract][Full Text] [Related]
30. Differential inhibition of acetylcholinesterase molecular forms in normal and Alzheimer disease brain.
Ogane N; Giacobini E; Struble R
Brain Res; 1992 Sep; 589(2):307-12. PubMed ID: 1393597
[TBL] [Abstract][Full Text] [Related]
31. Lateralization of brain morphologic and cholinergic abnormalities in Alzheimer's disease.
Moossy J; Zubenko GS; Martinez AJ; Rao GR; Kopp U; Hanin I
Arch Neurol; 1989 Jun; 46(6):639-42. PubMed ID: 2730376
[TBL] [Abstract][Full Text] [Related]
32. Current concepts in the treatment of Alzheimer's disease.
Sclar DA; Skaer TL
Clin Ther; 1992; 14(1):2-10; discussion 1. PubMed ID: 1576622
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics of tetrahydroaminoacridine: relations to clinical and biochemical effects in Alzheimer patients.
Ahlin A; Adem A; Junthé T; Ohman G; Nybäck H
Int Clin Psychopharmacol; 1992; 7(1):29-36. PubMed ID: 1624754
[TBL] [Abstract][Full Text] [Related]
34. Estimation of cholinesterase activity (EC 3.1.1.7; 3.1.1.8) in undiluted plasma and erythrocytes as a tool for measuring in vivo effects of reversible inhibitors.
Thomsen T; Kewitz H; Pleul O
J Clin Chem Clin Biochem; 1988 Jul; 26(7):469-75. PubMed ID: 3065439
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of rat brain histamine-N-methyltransferase by 9-amino-1,2,3,4-tetrahydroacridine (THA).
Cumming P; Reiner PB; Vincent SR
Biochem Pharmacol; 1990 Sep; 40(6):1345-50. PubMed ID: 2403387
[TBL] [Abstract][Full Text] [Related]
36. Effects of tetrahydroaminoacridine (tacrine) derivatives and physostigmine in convulsions induced by pentylenetetrazol.
Herink J; Koupilová M; Hrdina V
Act Nerv Super (Praha); 1989 Dec; 31(4):303-5. PubMed ID: 2638124
[No Abstract] [Full Text] [Related]
37. Multiple effects of tetrahydroaminoacridine on the cholinergic system: biochemical and behavioural aspects.
Adem A; Mohammed AK; Winblad B
J Neural Transm Park Dis Dement Sect; 1990; 2(2):113-28. PubMed ID: 2222779
[TBL] [Abstract][Full Text] [Related]
38. Electron microscopic localization of cholinesterase activity in Alzheimer brain tissue.
Carson KA; Geula C; Mesulam MM
Brain Res; 1991 Feb; 540(1-2):204-8. PubMed ID: 2054612
[TBL] [Abstract][Full Text] [Related]
39. In vitro effects of various cholinesterase inhibitors on acetyl- and butyrylcholinesterase of healthy volunteers.
Thomsen T; Zendeh B; Fischer JP; Kewitz H
Biochem Pharmacol; 1991 Jan; 41(1):139-41. PubMed ID: 1986738
[No Abstract] [Full Text] [Related]
40. Effects of tacrine derivatives on the behaviour of laboratory rats.
Koupilová M; Herink J; Hrdina V
Act Nerv Super (Praha); 1989 Dec; 31(4):301-3. PubMed ID: 2638123
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
